Literature DB >> 28210546

Time interval of neoadjuvant chemotherapy to surgery in breast cancer: how long is acceptable?

Tae-Kyung Yoo1, Hyeong-Gon Moon2, Wonshik Han2, Dong-Young Noh2.   

Abstract

Entities:  

Year:  2017        PMID: 28210546      PMCID: PMC5293647          DOI: 10.21037/gs.2016.08.06

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


× No keyword cloud information.
  15 in total

1.  Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.

Authors:  Sibylle Loibl; Gunter von Minckwitz; Günther Raab; Jens-Uwe Blohmer; Serban Dan Costa; Bernd Gerber; Holger Eidtmann; Simone Petrich; Jörn Hilfrich; Christian Jackisch; Andreas du Bois; Manfred Kaufmann
Journal:  Ann Surg Oncol       Date:  2006-09-17       Impact factor: 5.344

2.  Preoperative delays in the US Medicare population with breast cancer.

Authors:  Richard J Bleicher; Karen Ruth; Elin R Sigurdson; Eric Ross; Yu-Ning Wong; Sameer A Patel; Marcia Boraas; Neal S Topham; Brian L Egleston
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

3.  Being in suspense: women's experiences awaiting breast cancer surgery.

Authors:  Sigrunn Drageset; Torill Christine Lindstrøm; Tove Giske; Kjell Underlid
Journal:  J Adv Nurs       Date:  2011-04-06       Impact factor: 3.187

4.  Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.

Authors:  Ian C Smith; Steven D Heys; Andrew W Hutcheon; Iain D Miller; Simon Payne; Fiona J Gilbert; Antoinne K Ah-See; Oleg Eremin; Leslie G Walker; Tarun K Sarkar; S Peter Eggleton; Keith N Ogston
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

Review 5.  Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Authors:  Patricia Cortazar; Lijun Zhang; Michael Untch; Keyur Mehta; Joseph P Costantino; Norman Wolmark; Hervé Bonnefoi; David Cameron; Luca Gianni; Pinuccia Valagussa; Sandra M Swain; Tatiana Prowell; Sibylle Loibl; D Lawrence Wickerham; Jan Bogaerts; Jose Baselga; Charles Perou; Gideon Blumenthal; Jens Blohmer; Eleftherios P Mamounas; Jonas Bergh; Vladimir Semiglazov; Robert Justice; Holger Eidtmann; Soonmyung Paik; Martine Piccart; Rajeshwari Sridhara; Peter A Fasching; Leen Slaets; Shenghui Tang; Bernd Gerber; Charles E Geyer; Richard Pazdur; Nina Ditsch; Priya Rastogi; Wolfgang Eiermann; Gunter von Minckwitz
Journal:  Lancet       Date:  2014-02-14       Impact factor: 79.321

6.  Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer.

Authors:  Mariana Chavez-MacGregor; Christina A Clarke; Daphne Y Lichtensztajn; Sharon H Giordano
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

7.  Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.

Authors:  Jonathan L Vandergrift; Joyce C Niland; Richard L Theriault; Stephen B Edge; Yu-Ning Wong; Loretta S Loftus; Tara M Breslin; Clifford A Hudis; Sara H Javid; Hope S Rugo; Samuel M Silver; Eva M Lepisto; Jane C Weeks
Journal:  J Natl Cancer Inst       Date:  2012-12-21       Impact factor: 13.506

8.  Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.

Authors:  Rachel A Sanford; Xiudong Lei; Carlos H Barcenas; Elizabeth A Mittendorf; Abigail S Caudle; Vicente Valero; Debu Tripathy; Sharon H Giordano; Mariana Chavez-MacGregor
Journal:  Ann Surg Oncol       Date:  2015-12-17       Impact factor: 5.344

9.  Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.

Authors:  Gunter von Minckwitz; Sherko Kümmel; Petra Vogel; Claus Hanusch; Holger Eidtmann; Jörn Hilfrich; Bernd Gerber; Jens Huober; Serban Dan Costa; Christian Jackisch; Sibylle Loibl; Keyur Mehta; Manfred Kaufmann
Journal:  J Natl Cancer Inst       Date:  2008-04-08       Impact factor: 13.506

10.  Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer.

Authors:  Tae-Kyung Yoo; Wonshik Han; Hyeong-Gon Moon; Jisun Kim; Jun Woo Lee; Min Kyoon Kim; Eunshin Lee; Jongjin Kim; Dong-Young Noh
Journal:  Cancer Res Treat       Date:  2015-10-22       Impact factor: 4.679

View more
  2 in total

1.  Management of non-invasive tumours, benign tumours and breast cancer during the COVID-19 pandemic: recommendations based on a Latin American survey.

Authors:  G Luis Pendola; Roberto Elizalde; Pablo Sitic Vargas; José Caicedo Mallarino; Eduardo González; José Parada; Mauricio Camus; Ricardo Schwartz; Enrique Bargalló; Ruffo Freitas; Mauricio Magalhaes Costa; Vilmar Marques de Oliveira; Paula Escobar; Miguel Oller; Luis Fernando Viaña; Antonio Jurado Bambino; Gustavo Sarria; Francisco Terrier; Roger Corrales; Valeria Sanabria; Juan Carlos Rodríguez Agostini; Gonzalo Vargas Chacón; Víctor Manuel Pérez; Verónica Avilés; José Galarreta; Guillermo Laviña; Jorge Pérez Fuentes; Lía Bueso de Castellanos; Bolívar Arboleda Osorio; Herbert Castillo; Claudia Figueroa
Journal:  Ecancermedicalscience       Date:  2020-10-06

2.  Impact of COVID-19 On Breast Cancer Management: A Radiological Prespective from A Tertiary Centre.

Authors:  Anjum Syed; Gangotri Kumari; Aakriti Kapoor; Satish Chaitanya; Prateek Sharda; Mriganki Chaudhary; Ananya Deori; Priyanka Gupta; Nilotpal Choudhary; Shalinee Rao; Bina Ravi
Journal:  Eur J Breast Health       Date:  2021-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.